Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
June 30, 2026
COVID variant success involves more than viral load
Hyrien Lab, Vaccine and Infectious Disease Division
Beyond neutralization: the secret life of ADCC antibodies
From the Overbaugh Lab, Human Biology Division
Double trouble: two forms of antigenic stimulation confer protection against COVID-19
From Dr. Aaron Hudson and colleagues, Vaccine and Infectious Disease Division
A COVID-19 Antiviral, Reconsidered: What modeling reveals about Molnupiravir
From the Schiffer Lab, Vaccine and Infectious Disease Division
A moving target: How spike’s shape determines immune escape in SARS-CoV-2
From the Bloom Lab, Basic Sciences Division
Data-driven enrollment for COVID-19 vaccine clinical trials
From the HIV Vaccine Trials Network/COVID-19 Prevention Network
RR tracks: a new way to measure viral transmission
From the Bedford Lab, Vaccine and Infectious Disease, Public Health and Human Biology Divisions
Natural born killers: harnessing innate immunity to fight severe infections
From the Joshua Hill lab, Vaccine and Infectious Disease Division
COVID watchdawgs: SARS-CoV-2 at UW in the pandemic’s early days
From the Chu and Weil Labs, UW Medicine, in collaboration with the Cancer Basic Biology Program of the Cancer Consortium and Fred Hutch Vaccine and Infectious Disease Division
Identificación de anticuerpos potentes y ampliamente neutralizantes contra los sarbecovirus, incluidos el SARS-CoV-1 y el SARS-CoV-2
Del Laboratorio Overbaugh, División de Biología Humana
Drs. Keith Jerome and Jesse Bloom elected fellows of American Academy of Microbiology
Fred Hutch researchers’ study of viruses evolves from basic understanding to practical applications
With respiratory infections rampant, experts urge masking and vaccination
Limited disease data makes it hard to accurately assess flu trends
Identification of potent and broadly-neutralizing antibodies against sarbecoviruses including SARS-CoV-1 and SARS-CoV-2
From the Overbaugh lab, Human Biology Division
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
¿Necesito otra vacuna de refuerzo contra el SRAS-CoV-2?
Del Dr. Bo Zhang y laboratorios colaboradores, División de Vacunas y Enfermedades Infecciosas
Long COVID: key risk factors in postmenopausal women
From the Neuhouser research group, Public Health Sciences Division
Do I need another SARS-CoV-2 booster vaccine?
From Dr. Bo Zhang and collaborating labs, Vaccine & Infectious Disease Division